May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Michael Hofman: Prognostic Power of PSMA PET from the Updated PROMISE Large International Registry
May 5, 2025, 02:08

Michael Hofman: Prognostic Power of PSMA PET from the Updated PROMISE Large International Registry

Michael Hofman, Director of Prostate Cancer Theranostics and Imaging Centre of Excellence (ProSTIC) at Peter MacCallum Cancer Centre, posted on X:

“Incredible prognostic power of PSMA PET from the updated PROMISE large international registry (PPP2): 3 and 5-yr survival data. Superior to NCCN risk score.
Data across initial stage, biochemical recurrence, “non-metastatic” castration-resistant, mSPC, MCRPC!!
Just out in European Association of Urology.”

Title: Updated Prostate Cancer Risk Groups by Prostate-specific Membrane Antigen Positron Emission Tomography Prostate Cancer Molecular Imaging Standardized Evaluation (PPP2): Results from an International Multicentre Registry Study.

Authors: Madeleine J. Karpinski, Kambiz Rahbar, Martin Bögemann, Laya Rahbar Nikoukar, Michael Schäfers, Sebastian Hoberück, Matthias Miederer, Tobias Hölscher, Sazan Rasul, Marcin Miszczyk, Francesco Lanfranchi, Matteo Bauckneht, Christian H. Pfob, Felix Kind, Karolien Goffin, Anika Hüsing, Claudia Kesch, Ken Herrmann, Martin Stuschke, Andrei Gafita, Wolfgang P. Fendler

Read The Full Article at European Urology.

Michael Hofman: Prognostic Power of PSMA PET from the Updated PROMISE Large International Registry

More posts featuring Michael Hofman.